cervical%20cancer%20-%20treatment
CERVICAL CANCER - TREATMENT
Treatment Guideline Chart
Patients with abnormal Pap smear are referred for colposcopy to screen for presence of cervical cancer.
Colposcopic exam should include inspection of the transformation zone, definition of the extent of the lesion and biopsy of the most abnormal area for tissue diagnosis.
The earliest stages of cervical carcinoma are generally asymptomatic.
Watery vaginal discharge, postcoital or postmenopausal bleeding, intermittent spotting, or abdominal pain may be present and is usually unrecognized by the patient.

Cervical%20cancer%20-%20treatment Treatment

Surgical Intervention

Stage IA1

Fertility is Desired

  • If with negative lymphovascular space invasion and cone biopsy with ≥1-mm negative margin, close observation or surveillance may be done      
    • In the absence of lymphovascular invasion, patients have a relatively low risk of lymphatic metastasis (<1%)
    • If margins are positive, repeat cone biopsy to assess depth of invasion or trachelectomy is recommended
  • If with lymphovascular invasion and if margins are positive on cone biopsy, repeat cone biopsy or trachelectomy is recommended
  • Since the rate of ovarian metastases is low, the ovaries may be preserved in young premenopausal patients(<50 years) 

Fertility Not Desired

  • If patient is medically inoperable and without lymphovascular space invasion and margins are negative on cone biopsy, observation is recommended 
  • If patient is medically and technically operable and without lymphovascular space invasion and margins are negative on cone biopsy, extrafascial hysterectomy can be done     
    • If margins are positive for dysplasia or carcinoma, consider repeating cone biopsy or perform extrafascial or modified radical hysterectomy with pelvic lymphadenectomy and mapping of sentinel lymph node may be performed
  • If with lymphovascular invasion, the following treatment options are recommended:
    • Modified radical hysterectomy with pelvic lymphadenectomy with or without mapping of sentinel lymph node 
    • Pelvic EBRT with brachytherapy
  • If without lymphovascular space invasion and with positive margins, repeat cold knife conization or loop electrosurgical excision procedure (LEEP) is recommended

Stage IA2

  • As there is definite potential for lymph node metastasis in these patients, pelvic lymph node dissection is required in the treatment protocol  

Fertility is Desired

  • Patients meeting all criteria for conservative surgery (no lymphovascular space invasion, negative cone margins, any grade squamous cell carcinoma or grade 1-2 adenocarcinoma, ≤2 cm tumor size, ≤10 mm depth of invasion, and with negative imaging for metastatic disease) are recommended for cone biopsy (if with negative margins) with pelvic lymphadenectomy or sentinel lymph node mapping
  • Patient may undergo radical trachelectomy, which has low morbidity, recurrence and mortality rates, plus pelvic lymphadenectomy
    • Sentinel lymph node mapping should be considered especially in patients with suspected or known pelvic nodal disease
  • Another option is cold knife conization or large loop excision of the transformation zone plus pelvic lymphadenectomy, or large cone biopsy plus extra-peritoneal or laparoscopic pelvic lymphadenectomy
    • Cone biopsy may be performed in basic-resource settings and cone biopsy with pelvic lymphadenectomy in limited-resource settings 
    • If margins are positive, repeat cone biopsy or trachelectomy may be performed; if margins are still positive, treat as stage IB
    • Sentinel lymph node mapping should be considered

Fertility Not Desired

  • Radical hysterectomy plus pelvic lymph node dissection is the recommended treatment
    • Sentinel lymph node mapping should be considered
    • Para-aortic lymph node dissection is also recommended
  • Extrafascial hysterectomy with pelvic lymphadenectomy or sentinel lymph node mapping is recommended for patients meeting all criteria for conservative surgery

Stage IB1, IB2 and IIA1

  • Surgical treatment is radical hysterectomy (for stage IB1 not meeting criteria for conservative surgery, IB2 and IIA1 only) and bilateral pelvic lymphadenectomy
  • Para-aortic lymphadenectomy is recommended especially in patients with larger tumors or ≥stage IB1 cancer
    •  Sentinel lymph node mapping can be considered
  • If there are positive lymph nodes on pelvic lymphadenectomy, radical hysterectomy is deferred and patient is referred for chemoradiation therapy     
  • Vaginal radical hysterectomy can be an alternative to radical abdominal hysterectomy
    • Preferred treatment for FIGO stage IA2, IB1, and select IIA1 lesions when fertility preservation is not desired
    • Should not be offered in patients with >2-cm tumor diameter
  • Extrafascial hysterectomy with pelvic lymphadenectomy or sentinel lymph node mapping is recommended for patients with stage IB1 tumors and meeting all criteria for conservative surgery

Fertility is Desired - Select Stage IB1 and Select Stage IB2

  • Patients who are candidates for fertility-sparing surgery are the following:
    • With largest diameter of tumor ≤2 cm
    • Without lymphovascular space involvement
    • Without lymph node involvement
  • Patients with stage IB1 tumors and meeting all criteria for conservative surgery are recommended for cone biopsy with pelvic lymphadenectomy or sentinel lymph node mapping
  • Patient may undergo radical vaginal trachelectomy plus pelvic lymphadenectomy for select stage IB1 (tumor <20 mm in diameter) with or without para-aortic lymphadenectomy
    • Sentinel lymph node mapping can be considered
    • In a study among women after radical trachelectomy for early stage cancer, the 5-year cumulative pregnancy rate was 52.8%, with low cancer recurrence rate but with higher miscarriage rate
  • Abdominal radical trachelectomy may be a fertility-sparing option for patients with stage IB2 tumor
Editor's Recommendations
Special Reports